February 14, 2019 — Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography Specialists of Decatur, Ga. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP (Enhancing Quality Using the Inspection Program) guidelines. TeleMammography Specialists will also implement the recently released densitasdensity automated breast density assessment software.
Densitas will highlight the benefits and capabilities of both products at the 2019 Healthcare Information and Management Systems Society (HIMSS) annual meeting, Feb. 11-15 in Orlando, Fla.
TeleMammography Specialists LLC. is an international teleradiology services provider that is specialized in breast imaging. Densitas Quality will help:
- Streamline efforts to meet the U.S. Food and Drug Administration’s (FDA) EQUIP guidelines and prepare for mammography inspections;
- Enable real-time feedback from the interpreting physicians to the technologists;
- Automate EQUIP audit documentation requirements of the lead interpreting physician/auditing physician;
- Simplify the ability to meet the proactive quality control requirements of EQUIP; and
- Identify technologist performance issues quickly and accurately to facilitate ongoing training and communication that improves image and service quality.
By making densitasquality and densitasdensity available to all of TeleMammography Specialists clients, over 60,000 women will benefit annually. "Densitas will help us provide consistent quality and standardize density assessment among our radiologists", said Martha H. Garrison, M.D., president and CEO of TeleMammography Specialists, LLC. "We will be able to more proactively manage the needs of our clients and provide consistently high quality of care."
The artificial intelligence (AI)-powered densitasdensity software delivers fully automated, standardized and reliably reproducible breast density assessment. Additionally, densitasdensity results can be incorporated in risk models to generate standardized and reliably reproducible breast cancer risk assessment.
For more information: www.densitas.health
June 12, 2026 
